Quick Dispatch:
Your bso glutathione inhibitor Combined inhibition of de novo glutathione and nucleotide biosynthesis is synthetically lethal in glioblastoma orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your bso glutathione inhibitor Combined inhibition of de novo glutathione and nucleotide biosynthesis is synthetically lethal in glioblastoma ships.
Need Help?
Questions about bso glutathione inhibitor Combined inhibition of de novo glutathione and nucleotide biosynthesis is synthetically lethal in glioblastoma, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for bso glutathione inhibitor Combined inhibition of de novo glutathione and nucleotide biosynthesis is synthetically lethal in glioblastoma in your area.
The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma
28.84
Glutathione depletion induces oxidative injury and apoptosis via TRPM2 channel activation in renal collecting duct cells
28.52
Deubiquitinases Maintain Protein Homeostasis and Survival of Cancer Cells upon Glutathione Depletion: Cell Metabolism
26.51
Combination of Paracetamol and the Glutathione Depleting Agent Buthionine Sulfoximine Show Differential Effect on Liver Cancer Cells and Normal Hepatocytes
23.90
Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis
26.67
Nucleotide biosynthesis links glutathione metabolism to ferroptosis sensitivity
28.70
Pro-Oxidant Auranofin and Glutathione-Depleting Combination Unveils Synergistic Lethality in Glioblastoma Cells with Aberrant Epidermal Growth Factor Receptor Expression
23.56
